SAN DIEGO , Jan. 17, 2017 /PRNewswire/ -- Portable Genomics and CFTechnology.org (CFT) are teaming up to bring a private and tailored health data management platform to cystic fibrosis (CF) patients' mobile devices and to engage the CF ...
LONDON , January 17, 2017 /PRNewswire/ -- International specialist veterinary pharmaceuticals and related products business , Dechra Pharmaceuticals PLC (Dechra or the Company) (Stock Code: Full Listing (Pharmaceuticals): DPH) issues the ...
NEW YORK , Jan. 16, 2017 /PRNewswire/ -- The active pharmaceutical ingredients market in terms of value is expected to reach USD 213.97 billion by 2021 from USD 157.95 billion in 2016, growing at a CAGR of 6.3% from 2016 to 2021. This ...
WESTERHAM, England , January 16, 2017 /PRNewswire/ -- A major investment in the leading source of drug discovery industry information - Drug Target Review - has led to a comprehensive relaunch. (Photo: ...
Alexander Nachman, a leading marijuana advocate, presents the social and economic benefits of regulated, legal cannabis NEW YORK , Jan. 16, 2017 /PRNewswire/ -- Alexander Nachman, one of the nation's leading experts on the medicinal, ...
NEW YORK , January 13, 2017 /PRNewswire/ -- The 2016 election resulted in a big win for the legal cannabis industry, with several states voting in favor of legalizing cannabis for recreational use, including California , the largest ...
TORONTO, Canada and MEDELLÍN, Colombia , Jan. 12, 2017 /CNW/ - PharmaCielo Ltd. President and CEO Dr. Patricio Stocker is pleased to announce two key initiatives designed to ensure that all PharmaCielo operations meet the highest global ...
NEW YORK , Jan. 12, 2017 /PRNewswire/ -- The Global Precision Medicine Market is poised to grow at a CAGR of around 11.2% over the next decade to reach approximately $112.62 billion by 2025. Some of the prominent trends that the market is ...
NEW YORK , Jan. 12, 2017 /PRNewswire/ -- The Global Transdermal Drug Delivery Market is poised to grow at a CAGR of around 11.6% over the next decade to reach approximately $95.57 billion by 2025. Some of the prominent trends that the ...
Poster presentation at ODAC Conference reports potential anti-inflammatory properties of minocycline ...
Dapagliflozin, a medication prescribed for managing Type 2 diabetes , has demonstrated additional benefits in heart failure conditions. This drug lowers the likelihood of hospitalization due to heart failure and mortality in ...
The efficacy of mRNA vaccine technology demonstrated during the COVID-19 pandemic provides optimism for its utilization in mitigating preventable illnesses across various disease domains ( ). ...
An intradermal monkeypox (Mpox) vaccination regimen with reduced dosage proved safe and elicited an antibody response comparable to the standard regimen at six weeks (two weeks post-second dose). ...
The World Health Organization (WHO) granted prequalification to a novel oral cholera vaccine on April 12. The Euvichol-S oral vaccine, which is inactivated, demonstrates comparable effectiveness to the current vaccines, ...
Alectinib, a molecule developed by Genentech, Inc has been granted approval by the Food and Drug Administration on April 18, 2024, for the adjuvant treatment of patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer ...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers